Department of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
BMC Pulm Med. 2011 Oct 6;11:47. doi: 10.1186/1471-2466-11-47.
Recent studies find that a considerable number of patients with pulmonary arterial hypertension (PAH) develop fibrous obstruction of the pulmonary veins. Such obstruction more commonly accompanies connective tissue disorder (CTD)-associated PAH than idiopathic PAH. However, few researchers have gauged the risk of death involving obstruction of the pulmonary veins.
Thirty-seven patients with PAH were enrolled (18 patients, idiopathic PAH; 19 patients, CTD-associated PAH). The patients were 49 ± 18 years and had a World Health Organization functional class of 3.2 ± 0.6. Thickening of the interlobular septa, centrilobular ground-glass attenuation, and mediastinal adenopathy were surrogates for obstruction of the pulmonary veins, and were detected by a 16-row multidetector computed tomography scanner.
The follow-up period was 714 ± 552 days. Fifteen deaths occurred. Thickening of the interlobular septa, centrilobular ground-glass attenuation, and mediastinal adenopathy were found in 37.8%, 24.3%, and 16.2% of patients, respectively. Cox proportional hazard analysis revealed an increased risk of death with each radiographic surrogate (mediastinal adenopathy: p < 0.0001, hazard ratio = 13.9; thickening of interlobular septa: p < 0.001, hazard ratio = 12.0; ground-glass attenuation: p = 0.02, hazard ratio = 3.7). The statistical significance of these relationships was independent of the cause of PAH and plasma concentration of brain natriuretic peptide.
The results of this study imply that obstruction of the pulmonary veins is associated with an increased risk of death in patients with PAH.
最近的研究发现,相当数量的肺动脉高压(PAH)患者会出现肺静脉纤维性阻塞。这种阻塞在结缔组织疾病(CTD)相关的 PAH 中比特发性 PAH 更为常见。然而,很少有研究评估肺静脉阻塞导致死亡的风险。
共纳入 37 例 PAH 患者(18 例特发性 PAH,19 例 CTD 相关 PAH)。患者年龄为 49±18 岁,WHO 功能分级为 3.2±0.6。用 16 排多层螺旋 CT 扫描仪检测肺静脉阻塞的替代指标,包括小叶间隔增厚、小叶中心磨玻璃影和纵隔淋巴结肿大。
中位随访时间为 714±552 天,共发生 15 例死亡。37.8%、24.3%和 16.2%的患者分别存在小叶间隔增厚、小叶中心磨玻璃影和纵隔淋巴结肿大。Cox 比例风险分析显示,每种影像学替代指标均与死亡风险增加相关(纵隔淋巴结肿大:p<0.0001,风险比=13.9;小叶间隔增厚:p<0.001,风险比=12.0;磨玻璃影:p=0.02,风险比=3.7)。这些关系的统计学意义独立于 PAH 的病因和脑钠肽的血浆浓度。
该研究结果表明,PAH 患者肺静脉阻塞与死亡风险增加相关。